BioCentury | Aug 19, 2013
Emerging Company Profile

PxRadia: Ceramide selectivity

PxRadia Inc. is developing a mAb that directly targets ceramide molecules in the cell membrane, blocking their ability to induce apoptosis in tissues subjected to stressors such as radiation. But the mAb doesn't impair normal...
BioCentury | Apr 26, 2012
Distillery Therapeutics

Indication: Gastrointestinal disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Gastrointestinal disease Gastrointestinal disease Ceramide A study in mice identified an anticeramide antibody called 2A2 that could help prevent or reduce radiation-induced...
Items per page:
1 - 2 of 2